The Market Reports

Index

1 Market Overview
1.1 Product Overview and Scope of Alzheimer's Disease Therapeutics and Diagnostics
1.2 Classification of Alzheimer's Disease Therapeutics and Diagnostics by Type
1.2.1 Overview: Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type in 2021
1.2.3 Biomarkers
1.2.4 Cholinesterase inhibitors
1.2.5 NMDA receptor antagonists
1.2.6 Brain imaging
1.2.7 Blood tests
1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market by Application
1.3.1 Overview: Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drugs Market
1.3.3 Diagnostics Market
1.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size & Forecast
1.5 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast by Region
1.5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Alzheimer's Disease Therapeutics and Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Alzheimer's Disease Therapeutics and Diagnostics Market Drivers
1.6.2 Alzheimer's Disease Therapeutics and Diagnostics Market Restraints
1.6.3 Alzheimer's Disease Therapeutics and Diagnostics Trends Analysis
2 Company Profiles
2.1 Namenda
2.1.1 Namenda Details
2.1.2 Namenda Major Business
2.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.1.4 Namenda Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Namenda Recent Developments and Future Plans
2.2 Aricept
2.2.1 Aricept Details
2.2.2 Aricept Major Business
2.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.2.4 Aricept Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Aricept Recent Developments and Future Plans
2.3 Exelon
2.3.1 Exelon Details
2.3.2 Exelon Major Business
2.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.3.4 Exelon Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Exelon Recent Developments and Future Plans
2.4 Solanezumab
2.4.1 Solanezumab Details
2.4.2 Solanezumab Major Business
2.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.4.4 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Solanezumab Recent Developments and Future Plans
2.5 Gantenerumab
2.5.1 Gantenerumab Details
2.5.2 Gantenerumab Major Business
2.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.5.4 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Gantenerumab Recent Developments and Future Plans
2.6 Verubecestat
2.6.1 Verubecestat Details
2.6.2 Verubecestat Major Business
2.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.6.4 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Verubecestat Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.7.4 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Eisai
2.8.1 Eisai Details
2.8.2 Eisai Major Business
2.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.8.4 Eisai Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Eisai Recent Developments and Future Plans
2.9 Actavis
2.9.1 Actavis Details
2.9.2 Actavis Major Business
2.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.9.4 Actavis Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Actavis Recent Developments and Future Plans
2.10 Lundbeck
2.10.1 Lundbeck Details
2.10.2 Lundbeck Major Business
2.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.10.4 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Lundbeck Recent Developments and Future Plans
2.11 Daiichi Sankyo
2.11.1 Daiichi Sankyo Details
2.11.2 Daiichi Sankyo Major Business
2.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.11.4 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Daiichi Sankyo Recent Developments and Future Plans
2.12 Novartis
2.12.1 Novartis Details
2.12.2 Novartis Major Business
2.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.12.4 Novartis Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Novartis Recent Developments and Future Plans
2.13 TauRx
2.13.1 TauRx Details
2.13.2 TauRx Major Business
2.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
2.13.4 TauRx Alzheimer's Disease Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 TauRx Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Alzheimer's Disease Therapeutics and Diagnostics Players Market Share in 2021
3.2.2 Top 10 Alzheimer's Disease Therapeutics and Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Alzheimer's Disease Therapeutics and Diagnostics Players Head Office, Products and Services Provided
3.4 Alzheimer's Disease Therapeutics and Diagnostics Mergers & Acquisitions
3.5 Alzheimer's Disease Therapeutics and Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2028)
6.2 North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2028)
6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
6.3.1 North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2028)
7.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2028)
7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
7.3.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region
8.3.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Region (2017-2028)
8.3.2 China Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2028)
9.2 South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2028)
9.3 South America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
9.3.1 South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
10.3.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Namenda Corporate Information, Head Office, and Major Competitors
Table 7. Namenda Major Business
Table 8. Namenda Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 9. Namenda Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Aricept Corporate Information, Head Office, and Major Competitors
Table 11. Aricept Major Business
Table 12. Aricept Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 13. Aricept Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Exelon Corporate Information, Head Office, and Major Competitors
Table 15. Exelon Major Business
Table 16. Exelon Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 17. Exelon Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Solanezumab Corporate Information, Head Office, and Major Competitors
Table 19. Solanezumab Major Business
Table 20. Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 21. Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Gantenerumab Corporate Information, Head Office, and Major Competitors
Table 23. Gantenerumab Major Business
Table 24. Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 25. Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Verubecestat Corporate Information, Head Office, and Major Competitors
Table 27. Verubecestat Major Business
Table 28. Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 29. Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 33. Pfizer Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Eisai Corporate Information, Head Office, and Major Competitors
Table 35. Eisai Major Business
Table 36. Eisai Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 37. Eisai Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Actavis Corporate Information, Head Office, and Major Competitors
Table 39. Actavis Major Business
Table 40. Actavis Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 41. Actavis Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Lundbeck Corporate Information, Head Office, and Major Competitors
Table 43. Lundbeck Major Business
Table 44. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 45. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 47. Daiichi Sankyo Major Business
Table 48. Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 49. Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Novartis Corporate Information, Head Office, and Major Competitors
Table 51. Novartis Major Business
Table 52. Novartis Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 53. Novartis Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. TauRx Corporate Information, Head Office, and Major Competitors
Table 55. TauRx Major Business
Table 56. TauRx Alzheimer's Disease Therapeutics and Diagnostics Product and Solutions
Table 57. TauRx Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Alzheimer's Disease Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Alzheimer's Disease Therapeutics and Diagnostics Players Head Office, Products and Services Provided
Table 62. Alzheimer's Disease Therapeutics and Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Alzheimer's Disease Therapeutics and Diagnostics New Entrants and Expansion Plans
Table 64. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 65. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Type (2017-2022)
Table 66. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Forecast by Type (2023-2028)
Table 67. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2022)
Table 68. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Forecast by Application (2023-2028)
Table 69. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Alzheimer's Disease Therapeutics and Diagnostics Picture
Figure 2. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type in 2021
Figure 3. Biomarkers
Figure 4. Cholinesterase inhibitors
Figure 5. NMDA receptor antagonists
Figure 6. Brain imaging
Figure 7. Blood tests
Figure 8. Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Application in 2021
Figure 9. Drugs Market Picture
Figure 10. Diagnostics Market Picture
Figure 11. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region (2017-2028)
Figure 14. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region in 2021
Figure 15. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Alzheimer's Disease Therapeutics and Diagnostics Market Drivers
Figure 21. Alzheimer's Disease Therapeutics and Diagnostics Market Restraints
Figure 22. Alzheimer's Disease Therapeutics and Diagnostics Market Trends
Figure 23. Namenda Recent Developments and Future Plans
Figure 24. Aricept Recent Developments and Future Plans
Figure 25. Exelon Recent Developments and Future Plans
Figure 26. Solanezumab Recent Developments and Future Plans
Figure 27. Gantenerumab Recent Developments and Future Plans
Figure 28. Verubecestat Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Eisai Recent Developments and Future Plans
Figure 31. Actavis Recent Developments and Future Plans
Figure 32. Lundbeck Recent Developments and Future Plans
Figure 33. Daiichi Sankyo Recent Developments and Future Plans
Figure 34. Novartis Recent Developments and Future Plans
Figure 35. TauRx Recent Developments and Future Plans
Figure 36. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players in 2021
Figure 37. Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share in 2021
Figure 39. Global Top 10 Players Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Type in 2021
Figure 42. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share Forecast by Type (2023-2028)
Figure 43. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Application in 2021
Figure 44. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share Forecast by Application (2023-2028)
Figure 45. North America Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Type (2017-2028)
Figure 46. North America Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2017-2028)
Figure 47. North America Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 48. United States Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Type (2017-2028)
Figure 52. Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2017-2028)
Figure 53. Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 54. Germany Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region (2017-2028)
Figure 62. China Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Type (2017-2028)
Figure 69. South America Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2017-2028)
Figure 70. South America Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source